At the news
? NEUTRALIMPACT 1/10 DEFA14A filed Mar 20, 2026 at 16:52 ET
Analysis based on filing metadata only, document content was unavailable
- Filing is a DEFA14A, which is a definitive additional materials proxy statement.
- Filed by the registrant, Emergent BioSolutions Inc.
- No fee required for filing.
- Document content was unavailable for analysis.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access